Adial Pharmaceuticals: That The Date Of Completion Of The Sale Of The Purnovate Assets And Business Referred To Therein Was August 17, 2023, And Correct The Date Of The Contractual Closing In The Notes To The Pro Forma Financials. As Previously Filed, The Cover Page Reflected An Incorrect Date Of Earliest Event Reported Of June 30, 2023, Which Was The Retroactive Effective Date Of The Sale Not The August 17, 2023 Date Of The Contractual Closing When The Closing Documents Were Finalized And The Retroactive Effective Date Of June 30, 2023 Was Agreed To, And The Notes To The Pro Forma Financials Incorrectly Implied That The Contractual Closing Took Place On June 30, 2023. No Other Changes Have Been Made To The Original Form 8k, Financial Statements And Exhibits
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameAdial Pharmaceuticals, Inc.
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









